JUMPCODE GENOMICS INC.

Company Overview

Jumpcode Genomics Inc., founded in 2016, is commercializing its CRISPRclean technology. This technology reduces the background noise in NGS libraries by using the CRISPR/Cas system to cleave and physically remove unwanted nucleic acid sequences from NGS libraries and leaving behind only the targets of interest.

The benefit of the CRISPRclean platform is that it enables customers to see what they previously could not.

Jumpcode offers several CRISPRclean kits for RNA, including Human rRNA Depletion kits, Pan Bacterial rRNA Depletion kits, Meta transcriptomics rRNA Depletion Kits, and Single Cell RNA Sequencing.

Applications for the technology in the clinical NGS markets include for genetic disease diagnosis, liquid biopsy and infectious diseases.

Company's Business Segments

• CRISPRclean Technology : The company provides a proprietary CRISPR-based technology (CRISPRclean) that enables researchers to remove unwanted sequences from biological samples, improving the sensitivity of next-generation sequencing (NGS).